✦ LIBER ✦

Treatment of HCV infection with pegylated interferons

✍ Scribed by Graham R. Foster; Abid R. Suddle

Book ID: 107540401
Publisher: Current Science Inc.
Year: 2005
Tongue: English
Weight: 372 KB
Volume: 4
Category: Article
ISSN: 1540-3416
DOI: 10.1007/s11901-005-0014-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Utility of a novel HCV-NS4 antigen detec

Utility of a novel HCV-NS4 antigen detection immunoassay for monitoring treatment of HCV-infected individuals with pegylated interferon α-2a

✍ Abdelfattah M. Attallah; Gamal E. Shiha; Camelia A. Abdel Malak; Hytham E. Hagra 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

HCV treatment with pegylated interferon

HCV treatment with pegylated interferon and ribavirin in patients with haemophilia and HIV/HCV co-infection

✍ J. T. DENHOLM; E. J. WRIGHT; A. STREET; J. J. SASADEUSZ 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB

A prospective study of T- and B-lymphocy

A prospective study of T- and B-lymphocyte subpopulations, CD81 expression levels on B cells and regulatory CD4+CD25+CD127low/−FoxP3+ T cells in patients with chronic HCV infection during pegylated interferon-alpha2a plus ribavirin treatment

✍ B. Soldevila; N. Alonso; M. J. Martínez-Arconada; R. M. Morillas; R. Planas; A. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 203 KB

Pegylated α interferon 2B plus ribavirin

Pegylated α interferon 2B plus ribavirin in the treatment of HCV genotype 4 infection

✍ Tawhida Yassin Abdel Ghaffar; Suzan El Naghy; Hatem El Sebaie; Magda El Monaiery 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 122 KB

Treatment with pegylated interferon and

Treatment with pegylated interferon and ribavarin in HCV infection with genotype 2 or 3 for 14 weeks: A pilot study

✍ Olav Dalgard; Kristian Bjøro; Kjell Block Hellum; Bjørn Myrvang; Ståle Ritland; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB

The aim of this study was to determine the efficacy of 14 weeks of treatment in patients infected with hepatitis C virus (HCV) genotype 2 or 3 who achieve early virological response (EVR). In a noncontrolled multicenter trial, 122 treatment-naive patients received 1.5 mug/kg pegylated interferon alf

Thrombotic microangiopathy complicating

Thrombotic microangiopathy complicating pegylated interferon treatment of hepatitis C infection

✍ Deena Iskander; Melissa Wickremasinghe; Barbara J. Bain 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB